毒学的な発作:特徴,結果,再発
Kristy McCulloch1,2, Ingrid Berling3, Angela L Chiew4
1Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia.
Clinical toxicology (Philadelphia, Pa.)
|September 4, 2025
まとめ
トラマドールとコカインの過剰摂取による毒性発作は一般的です 多くの患者は発作が再発したり,を発症したりするので,厳密な追跡が必要になります.
科学分野:
- 臨床毒理学
- 神経科学
- 薬理学について
背景:
- 薬物の過剰摂取後の重度の毒性の重要な指標である.
- 毒性発作の特徴,原因,再発パターンに関する研究は限られている.
研究 の 目的:
- 薬物の過剰投与を呈した患者の毒性発作を調査する.
- 発作の原因を特定する
- 発作の再発の頻度とそれに続くの診断を決定する.
主な方法:
- 薬物の過剰摂取による発作を患った患者の遡及観察研究.
- オーストラリアの3つの臨床毒理学ユニットから収集されたデータ (2014-2022年).
- 分析には,患者の人口統計,病原体,発作の特徴,およびフォローアップデータが含まれていた.
主要な成果:
- 9年間で284件の発作 (275人の患者) が発生しました.
- トラマドール,3,4-メチレンディオキシメタムフェタミン,クエチアピンは一般的な発作薬である.
- 20% の患者で発作が再発し,4% の患者でが診断された.
結論:
- 毒性発作は トラマドール,コカイン,合成カンナビノイド受容体アゴニストなどの特定の薬物と頻繁に関連しています.
- 過剰摂取後に発作が再発したり,を発症したりする患者はかなり多い.
- 毒性発作の厳格な調査,管理,フォローアップは,誘発されていない発作に似ています.
関連する概念動画
01:24Epilepsy and Seizures: Overview
274
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
274
01:13Seizures: Classification
582
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
582
01:26Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
01:20Antiepileptic Drugs: Potassium Channel Activators
272
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
272
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
439
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
439
01:30Electroconvulsive Therapy
181
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
181